Food & Beverage Industry News, Products
date:Sep 17, 2015
om high-amylose corn and reduction of risk for type 2 diabetes, said Christine Pelkman, Ph.D., senior nutrition scientist and clinical research manager, Ingredion. We collaborated with external scientific and regulatory experts who indicated that these findings provide a strong basis for a health-claim petition for reducing the risk for this disease. Eight well-controlled clinical trials showed HI-MAIZE resistant starch from high-amylose corn improved insulin sensitivity or other biomarkers acce
16/19 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
05/02 17:47